188 related articles for article (PubMed ID: 32866655)
1. Inherited Rare, Deleterious Variants in ATM Increase Lung Adenocarcinoma Risk.
Esai Selvan M; Zauderer MG; Rudin CM; Jones S; Mukherjee S; Offit K; Onel K; Rennert G; Velculescu VE; Lipkin SM; Klein RJ; Gümüş ZH
J Thorac Oncol; 2020 Dec; 15(12):1871-1879. PubMed ID: 32866655
[TBL] [Abstract][Full Text] [Related]
2. Rare, Pathogenic Germline Variants in
Esai Selvan M; Klein RJ; Gümüş ZH
Clin Cancer Res; 2019 Mar; 25(5):1517-1525. PubMed ID: 30425093
[TBL] [Abstract][Full Text] [Related]
3. Somatic and germline ATM variants in non-small-cell lung cancer: Therapeutic implications.
Hernandez-Martinez JM; Rosell R; Arrieta O
Crit Rev Oncol Hematol; 2023 Aug; 188():104058. PubMed ID: 37343657
[TBL] [Abstract][Full Text] [Related]
4. Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma.
Patiño-García A; Guruceaga E; Andueza MP; Ocón M; Fodop Sokoudjou JJ; de Villalonga Zornoza N; Alkorta-Aranburu G; Uria IT; Gurpide A; Camps C; Jantus-Lewintre E; Navamuel-Andueza M; Sanmamed MF; Melero I; Elgendy M; Fusco JP; Zulueta JJ; de-Torres JP; Bastarrika G; Seijo L; Pio R; Montuenga LM; Hernáez M; Ochoa I; Perez-Gracia JL
EBioMedicine; 2024 Apr; 102():105048. PubMed ID: 38484556
[TBL] [Abstract][Full Text] [Related]
5. Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study.
Shi J; Hua X; Zhu B; Ravichandran S; Wang M; Nguyen C; Brodie SA; Palleschi A; Alloisio M; Pariscenti G; Jones K; Zhou W; Bouk AJ; Boland J; Hicks B; Risch A; Bennett H; Luke BT; Song L; Duan J; Liu P; Kohno T; Chen Q; Meerzaman D; Marconett C; Laird-Offringa I; Mills I; Caporaso NE; Gail MH; Pesatori AC; Consonni D; Bertazzi PA; Chanock SJ; Landi MT
PLoS Med; 2016 Dec; 13(12):e1002162. PubMed ID: 27923066
[TBL] [Abstract][Full Text] [Related]
6. Protein-altering germline mutations implicate novel genes related to lung cancer development.
Ji X; Mukherjee S; Landi MT; Bosse Y; Joubert P; Zhu D; Gorlov I; Xiao X; Han Y; Gorlova O; Hung RJ; Brhane Y; Carreras-Torres R; Christiani DC; Caporaso N; Johansson M; Liu G; Bojesen SE; Le Marchand L; Albanes D; Bickeböller H; Aldrich MC; Bush WS; Tardon A; Rennert G; Chen C; Byun J; Dragnev KH; Field JK; Kiemeney LF; Lazarus P; Zienolddiny S; Lam S; Schabath MB; Andrew AS; Bertazzi PA; Pesatori AC; Diao N; Su L; Song L; Zhang R; Leighl N; Johansen JS; Mellemgaard A; Saliba W; Haiman C; Wilkens L; Fernandez-Somoano A; Fernandez-Tardon G; Heijden EHFMV; Kim JH; Davies MPA; Marcus MW; Brunnström H; Manjer J; Melander O; Muller DC; Overvad K; Trichopoulou A; Tumino R; Goodman GE; Cox A; Taylor F; Woll P; Wichmann E; Muley T; Risch A; Rosenberger A; Grankvist K; Johansson M; Shepherd F; Tsao MS; Arnold SM; Haura EB; Bolca C; Holcatova I; Janout V; Kontic M; Lissowska J; Mukeria A; Ognjanovic S; Orlowski TM; Scelo G; Swiatkowska B; Zaridze D; Bakke P; Skaug V; Butler LM; Offit K; Srinivasan P; Bandlamudi C; Hellmann MD; Solit DB; Robson ME; Rudin CM; Stadler ZK; Taylor BS; Berger MF; Houlston R; McLaughlin J; Stevens V; Nickle DC; Obeidat M; Timens W; Artigas MS; Shete S; Brenner H; Chanock S; Brennan P; McKay JD; Amos CI
Nat Commun; 2020 May; 11(1):2220. PubMed ID: 32393777
[TBL] [Abstract][Full Text] [Related]
7. Rare germline deleterious variants increase susceptibility for lung cancer.
Sang J; Zhang T; Kim J; Li M; Pesatori AC; Consonni D; Song L; Liu J; Zhao W; Hoang PH; Campbell DS; Feng J; D'Arcy ME; Synnott N; Chen Y; Wu Z; Zhu B; Yang XR; Brown KM; Choi J; Shi J; Landi MT
Hum Mol Genet; 2022 Oct; 31(20):3558-3565. PubMed ID: 35717579
[TBL] [Abstract][Full Text] [Related]
8. Almost 2% of Spanish breast cancer families are associated to germline pathogenic mutations in the ATM gene.
Tavera-Tapia A; Pérez-Cabornero L; Macías JA; Ceballos MI; Roncador G; de la Hoya M; Barroso A; Felipe-Ponce V; Serrano-Blanch R; Hinojo C; Miramar-Gallart MD; Urioste M; Caldés T; Santillan-Garzón S; Benitez J; Osorio A
Breast Cancer Res Treat; 2017 Feb; 161(3):597-604. PubMed ID: 27913932
[TBL] [Abstract][Full Text] [Related]
9. Rare germline ATM variants of uncertain significance in chronic lymphocytic leukaemia and other cancers.
Petrackova A; Savara J; Turcsanyi P; Gajdos P; Papajik T; Kriegova E
Br J Haematol; 2022 Nov; 199(3):371-381. PubMed ID: 36029002
[TBL] [Abstract][Full Text] [Related]
10. Germline rare deleterious variant load alters cancer risk, age of onset and tumor characteristics.
Esai Selvan M; Onel K; Gnjatic S; Klein RJ; Gümüş ZH
NPJ Precis Oncol; 2023 Jan; 7(1):13. PubMed ID: 36707626
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
12. Whole exome sequencing and MicroRNA profiling of lung adenocarcinoma identified risk prediction features for tumors at stage I and its substages.
Ho H; Yu SL; Chen HY; Yuan SS; Su KY; Hsu YC; Hsu CP; Chuang CY; Chang YH; Li YC; Cheng CL; Chang GC; Yang PC; Li KC
Lung Cancer; 2023 Oct; 184():107352. PubMed ID: 37657238
[TBL] [Abstract][Full Text] [Related]
13. Single nucleotide polymorphism in ATM gene, cooking oil fumes and lung adenocarcinoma susceptibility in Chinese female non-smokers: a case-control study.
Shen L; Yin Z; Wu W; Ren Y; Li X; Zhou B
PLoS One; 2014; 9(5):e96911. PubMed ID: 24819391
[TBL] [Abstract][Full Text] [Related]
14. Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers.
Renault AL; Mebirouk N; Fuhrmann L; Bataillon G; Cavaciuti E; Le Gal D; Girard E; Popova T; La Rosa P; Beauvallet J; Eon-Marchais S; Dondon MG; d'Enghien CD; Laugé A; Chemlali W; Raynal V; Labbé M; Bièche I; Baulande S; Bay JO; Berthet P; Caron O; Buecher B; Faivre L; Fresnay M; Gauthier-Villars M; Gesta P; Janin N; Lejeune S; Maugard C; Moutton S; Venat-Bouvet L; Zattara H; Fricker JP; Gladieff L; Coupier I; ; ; ; Chenevix-Trench G; Hall J; Vincent-Salomon A; Stoppa-Lyonnet D; Andrieu N; Lesueur F
Breast Cancer Res; 2018 Apr; 20(1):28. PubMed ID: 29665859
[TBL] [Abstract][Full Text] [Related]
15. Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma.
Shih DJH; Nayyar N; Bihun I; Dagogo-Jack I; Gill CM; Aquilanti E; Bertalan M; Kaplan A; D'Andrea MR; Chukwueke U; Ippen FM; Alvarez-Breckenridge C; Camarda ND; Lastrapes M; McCabe D; Kuter B; Kaufman B; Strickland MR; Martinez-Gutierrez JC; Nagabhushan D; De Sauvage M; White MD; Castro BA; Hoang K; Kaneb A; Batchelor ED; Paek SH; Park SH; Martinez-Lage M; Berghoff AS; Merrill P; Gerstner ER; Batchelor TT; Frosch MP; Frazier RP; Borger DR; Iafrate AJ; Johnson BE; Santagata S; Preusser M; Cahill DP; Carter SL; Brastianos PK
Nat Genet; 2020 Apr; 52(4):371-377. PubMed ID: 32203465
[TBL] [Abstract][Full Text] [Related]
16. NF1 patient missense variants predict a role for ATM in modifying neurofibroma initiation.
Yu Y; Choi K; Wu J; Andreassen PR; Dexheimer PJ; Keddache M; Brems H; Spinner RJ; Cancelas JA; Martin LJ; Wallace MR; Legius E; Vogel KS; Ratner N
Acta Neuropathol; 2020 Jan; 139(1):157-174. PubMed ID: 31664505
[TBL] [Abstract][Full Text] [Related]
17. A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma.
Li F; Ge D; Sun SL
BMC Pulm Med; 2021 Jul; 21(1):229. PubMed ID: 34256754
[TBL] [Abstract][Full Text] [Related]
18. Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up.
Kadara H; Choi M; Zhang J; Parra ER; Rodriguez-Canales J; Gaffney SG; Zhao Z; Behrens C; Fujimoto J; Chow C; Yoo Y; Kalhor N; Moran C; Rimm D; Swisher S; Gibbons DL; Heymach J; Kaftan E; Townsend JP; Lynch TJ; Schlessinger J; Lee J; Lifton RP; Wistuba II; Herbst RS
Ann Oncol; 2017 Jan; 28(1):75-82. PubMed ID: 27687306
[TBL] [Abstract][Full Text] [Related]
19. Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma.
Pastorino L; Dalmasso B; Allavena E; Vanni I; Ugolini F; Baroni G; Croce M; Guadagno A; Cabiddu F; Andreotti V; Bruno W; Zoppoli G; Ferrando L; Tanda ET; Spagnolo F; Menin C; Gangemi R; Massi D; Ghiorzo P
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555667
[TBL] [Abstract][Full Text] [Related]
20. Identification of heritable rare variants associated with early-stage lung adenocarcinoma risk.
Fu R; Zhang JT; Chen RR; Li H; Tai ZX; Lin HX; Su J; Chu XP; Zhang C; Qiu ZB; Chen ZH; Tang WF; Dong S; Yang XN; Zhang GQ; Zhao GP; Wu YL; Zhong WZ
Transl Lung Cancer Res; 2022 Apr; 11(4):509-522. PubMed ID: 35529798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
